FibroBiologics, Inc. Common Stock ( FBLG) - Key Metrics
FBLG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.66 | -$0.52 | -$0.52 |
| 2026Q1 | $0 | -$1.33 | -$1.16 | -$1.16 |
| 2025Q4 | $0 | -$0.98 | -$0.95 | -$0.95 |
| 2025Q3 | $0 | -$2.68 | -$1.84 | -$1.85 |
| 2025Q2 | $0 | -$2.41 | -$2.06 | -$2.17 |
FBLG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.36 |
| 2026Q1 | 0% | -0.25 |
| 2025Q4 | 0% | -1.15 |
| 2025Q3 | 0% | -1.05 |
| 2025Q2 | 0% | -1.30 |
FBLG
Price: $1.44
52 week price:
Earnings Per Share: -5.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.3 million